Latest filing published 06 Apr 2011 for GENZYME CORP.
No signal scores available.
Richard F/ca Syron discloses dealings in Genzyme Corp to SEC (Form 4). In total, 6 filings cover trades dated from 21 May 2009 to 4 April 2011.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 6 April 2011, reports an option exercise in Genzyme Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations